Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE

K-Number: K800623 · 1980-04-24

ApplicantPilling Co.
Decision Date1980-04-24
Product CodeKCD
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE is the device name listed in this FDA 510(k) record. The listed applicant is Pilling Co.. It received FDA 510(k) clearance on 1980-04-24 under 510(k) number K800623. The device is classified under product code KCD. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE?

JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE is a medical device that received FDA 510(k) clearance on 1980-04-24. The listed applicant is Pilling Co.. The 510(k) number is K800623.

When did JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE receive FDA 510(k) clearance?

JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE received FDA 510(k) clearance on 1980-04-24, under 510(k) number K800623.

Who is the listed applicant for JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE?

The FDA 510(k) record lists Pilling Co. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE?

The FDA product code for JACKSON ESOPHAGEAL BOUGIE, X-RAY OPAQUE is KCD.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Pilling Co. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K934427PILLING LAPAROSCOPIC INSTRUMENTATIONK925370TRIANGULAR JAW MICROLARYNGEAL FORCEPSK925198KAISER NO CANNULA THORACOSCOPY/LAPAROSCOPY INSTRK922971NO-SCALPEL VASCETOMY INSTRUMENTSK914015CLEMENT-PILLING CHOLANGIOGRAPHY CATH GUIDE/CLAMPK911099MEHIGAN-PILLING ANGIOSCOPIC VASCULAR INSTRUM. LINE

View all 39 devices →

Related Devices (Code: KCD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K844169VOLUMATICGlaxo, Inc.K822258ESOPHAGEAL BOUGIESKelleher Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑